Cambridge Investment Research Advisors, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 34,548 shares of DNA stock, worth $195,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,548
Previous 38,264
9.71%
Holding current value
$195,196
Previous $44,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$808 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$785 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$760 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$395 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$237 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $7.28B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...